This inventor holds 4 USPTO granted patents. Top assignees: Hanlim Pharmaceutical Co., Ltd., Hamlim Pharmaceutical Co., Ltd.. Active years: 2007-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2009
Title: The Innovative Contributions of Mun Choun Ha
Introduction: Mun Choun Ha is a distinguished inventor based in Yongin, South Korea. With a remarkable portfolio of four patents, he has made significant strides in the field of pharmaceutical innovation. His work reflects a commitment to developing novel compounds that have the potential to enhance medical treatments.
Latest Patents: Among his latest inventions are two noteworthy patents. The first patent involves S-(-)-amlodipine nicotinate and a process for its preparation. This innovative work provides a novel salt of S-(-)-amlodipine that includes a nicotinic acid salt and outlines a pharmaceutical composition that utilizes this as an active ingredient. The second patent details processes for the preparation of S-(-)-amlodipine from (R,S)-amlodipine in an industrial-scale context, utilizing L-(+)-tartaric acid, which is significantly more cost-effective than D-(-)-tartaric acid.
Career Highlights: Mun Choun Ha's career is marked by his contributions to the pharmaceutical industry, where he has held key roles at various pharmaceutical companies. Notably, he has worked with Hanlim Pharmaceutical Co., Ltd., where he utilized his expertise to advance innovative drug formulations and processes.
Collaborations: Throughout his career, Mun Choun Ha has collaborated with several talented professionals, including his coworker You Sup Chung. These collaborations have enriched his research and development efforts, leading to the successful realization of his patent applications.
Conclusion: Mun Choun Ha stands out as a prominent figure in pharmaceutical innovation. His inventions not only contribute to the scientific community but also pave the way for new therapeutic possibilities in medicine. With a strong foundation of patents and collaborations, his work continues to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile